| Application no. and date | 99956108.7 (espacenet) (Federated) (European Patent Register), 19991122 | | Patent/reg. no. and date | DK/EP 1133295, 20030903 | | Publication date | 20010919 | | Priority no. and date | FR 9814794, 19981124 | | EP pub. no. and date |
EP 1133295 20010919 | | Effective date | | | Applicant/owner | Aventis Pharma S.A., 20, avenue Raymond Aron
92160 Antony, FR | | Applicant ref. no. | 114452 | | Inventor | MEININGER, Vincent, 12, rue Stanislas
F-75006 Paris, FR,
DIB, Michel, 11, rue Henri Michaux
F-75013 Paris, FR | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61P 21/00, A61P 25/00, A61K 31/48 | | Title | Anvendelse af nicergolin ved behandling af spasticitet | | Int. application no. | FR1999002866 | | Int. publication no. | WO2000030642 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
